Study 19: Olaparib Maintenance in Platinum-Sensitive Relapsed Ovarian Cancer Last updated on Jun 5, 2026 Previous GOG 218: Bevacizumab in Front-Line Ovarian Cancer Next ARIEL3: Rucaparib Maintenance in Recurrent Ovarian Cancer
